Research and Markets: China Pharmaceutical Industry: Analysis and Market Trends

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/81c5d0/china_pharmaceutic) has announced the addition of the "China Pharmaceutical Industry: Analysis and Market Trends" report to their offering.

The pharmaceutical industry is one of the leading industries in China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.

This report examines the Chinese Pharmaceutical Industry in-depth and focuses on the impact the WTO accession of China has had on the Chinese pharmaceutical industry, trends, and competition.

China accounts for 20% of the world's population but only 1.5% of the global drug market. China's changing healthcare environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. The Chinese pharmaceutical industry is expected to continue its expansion.

The domestic China pharmaceutical market is highly fragmented and inefficient. Adverse factors include a lack of protection of intellectual property rights, a lack of visibility for drug approval procedures, a lack of effective governmental incentives, poor corporate support for drug research, and differences in the treatment in China accorded to local and foreign firms.

Even so, the industry environment has been transformed for the better over the last 10 years. Entry to the WTO has brought a stronger patent system, medical insurance is now more widespread, and pharmaceutical-related regulations have been stiffened. China is reportedly expected to become the third largest pharmaceuticals market in the world by 2011.

Companies Mentioned:

• AstraZeneca PLC
• Beijing Double-Crane Pharmaceutical (DCPC)
• Beijing TongRenTang Co, Ltd
• GlaxoSmithKline Plc
• Northeast Pharmaceutical Group (NEPG)
• Pfizer Inc
• Sanjiu Medical and Pharmaceutical Co Ltd (SMPCL)
• Shanghai Pharmaceutical Co Ltd

For more information visit http://www.researchandmarkets.com/research/81c5d0/china_pharmaceutic

Research and MarketsLaura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
[email protected]

Source: Research and Markets